Evaluation of Dry Eye Disease's Signs in Patients Who Were Administered Intravitreal Anti-VEGF Injections

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 5, 2024

Primary Completion Date

May 12, 2025

Study Completion Date

May 12, 2025

Conditions
Dry Eye Syndromes
Interventions
DEVICE

Thealoz Duo;

THEALOZ DUO is a solution containing trehalose (3%), sodium hyaluronate (0.15%), sodium chloride, trometamol, hydrochloric acid, and water for injections; Hydraback is a solution containing a sodium chloride 0.9 %, sodium dihydrogen phosphate dihydrate, sodium phosphate dodecahydrate, water for preparations for injection.

DEVICE

sham (Hydrabak)

Hydrabak is an ophthalmic solution containing: sodium chloride 0.9%, sodium dihydrogen phosphate dihydrate, sodium phosphate dodecahydrate, and water for injectable preparations

Trial Locations (1)

20123

RECRUITING

IRCCS Ospedale San Raffaele _O.U. Ophthalmology, Milan

All Listed Sponsors
lead

Francesco Bandello

OTHER